Axogen Inc has a consensus price target of $19.5 based on the ratings of 12 analysts. The high is $30 issued by Lake Street on March 17, 2025. The low is $9 issued by Leerink Partners on October 16, 2023. The 3 most-recent analyst ratings were released by Lake Street, Cantor Fitzgerald, and Citizens Capital Markets on March 17, 2025, March 5, 2025, and March 5, 2025, respectively. With an average price target of $26.67 between Lake Street, Cantor Fitzgerald, and Citizens Capital Markets, there's an implied 73.16% upside for Axogen Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/17/2025 | Buy Now | 94.81% | Lake Street | Frank Takkinen34% | → $30 | Initiates | → Buy | Get Alert |
03/05/2025 | Buy Now | 55.84% | Cantor Fitzgerald | Ross Osborn43% | $24 → $24 | Reiterates | Overweight → Overweight | Get Alert |
03/05/2025 | Buy Now | 68.83% | Citizens Capital Markets | David Turkaly53% | $26 → $26 | Reiterates | Market Outperform → Market Outperform | Get Alert |
02/26/2025 | Buy Now | 68.83% | Canaccord Genuity | Caitlin Cronin39% | $22 → $26 | Maintains | Buy | Get Alert |
02/26/2025 | Buy Now | 68.83% | Citizens Capital Markets | Constantine Davides37% | $20 → $26 | Maintains | Market Outperform | Get Alert |
02/03/2025 | Buy Now | 42.86% | Canaccord Genuity | Caitlin Cronin39% | $18 → $22 | Maintains | Buy | Get Alert |
08/09/2024 | Buy Now | 29.87% | JMP Securities | David Turkaly53% | $17 → $20 | Maintains | Market Outperform | Get Alert |
07/01/2024 | Buy Now | -15.58% | Raymond James | Jayson Bedford69% | → $13 | Initiates | → Outperform | Get Alert |
06/20/2024 | Buy Now | -2.6% | Canaccord Genuity | Caitlin Cronin39% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
01/19/2024 | Buy Now | -22.08% | Cantor Fitzgerald | Ross Osborn43% | $12 → $12 | Reiterates | Overweight → Overweight | Get Alert |
12/07/2023 | Buy Now | -28.57% | Canaccord Genuity | Caitlin Cronin39% | $15 → $11 | Reiterates | Buy → Buy | Get Alert |
10/16/2023 | Buy Now | -41.56% | Leerink Partners | Mike Kratky64% | → $9 | Initiates | → Outperform | Get Alert |
09/26/2023 | Buy Now | 3.9% | Cantor Fitzgerald | Ross Osborn43% | → $16 | Reiterates | Overweight → Overweight | Get Alert |
08/22/2023 | Buy Now | 3.9% | Cantor Fitzgerald | Travis Steed60% | → $16 | Reiterates | Overweight → Overweight | Get Alert |
05/10/2023 | Buy Now | 29.87% | JMP Securities | David Turkaly53% | → $20 | Reiterates | → Market Outperform | Get Alert |
03/28/2023 | Buy Now | -2.6% | Canaccord Genuity | Kyle Rose67% | $15 → $15 | Reiterates | → Buy | Get Alert |
03/15/2023 | Buy Now | 29.87% | JMP Securities | David Turkaly53% | → $20 | Reiterates | → Market Outperform | Get Alert |
11/11/2022 | Buy Now | -2.6% | Jefferies | Michael Sarcone10% | → $15 | Assumes | → Buy | Get Alert |
05/09/2022 | Buy Now | -2.6% | Canaccord Genuity | Kyle Rose67% | $10 → $15 | Upgrade | Hold → Buy | Get Alert |
05/05/2022 | Buy Now | -9.09% | SVB Leerink | Danielle Antalffy58% | $12 → $14 | Maintains | Outperform | Get Alert |
The latest price target for Axogen (NASDAQ:AXGN) was reported by Lake Street on March 17, 2025. The analyst firm set a price target for $30.00 expecting AXGN to rise to within 12 months (a possible 94.81% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Axogen (NASDAQ:AXGN) was provided by Lake Street, and Axogen initiated their buy rating.
The last upgrade for Axogen Inc happened on May 9, 2022 when Canaccord Genuity raised their price target to $15. Canaccord Genuity previously had a hold for Axogen Inc.
There is no last downgrade for Axogen.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axogen was filed on March 17, 2025 so you should expect the next rating to be made available sometime around March 17, 2026.
While ratings are subjective and will change, the latest Axogen (AXGN) rating was a initiated with a price target of $0.00 to $30.00. The current price Axogen (AXGN) is trading at is $15.40, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.